// App-Quantinova.ai

2089 : Therapeutic index prediction of the agonistic aglycosylated TWEAK receptor binding antibody BAY-356

Researchers

Presenter

  • Anders Viberg

Principal Investigators

  • Eva Hanze

  • Lisa Dietz

  • Ruprecht Zierz

  • Sandra Berndt

  • Sabine Wittemer-Rump

Medical Centers

  • qPharmetra, Stockholm, Sweden

  • Bayer Pharma AG, Berlin, Germany

  • Bayer, Berlin, Germany

Locations

  • Germany

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved